Company Search:
Advanced Search
Sponsored Links
Johnson & Johnson Company Snapshot
Johnson & Johnson operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Johnson & Johnson with three other major healthcare and pharmaceutical companies: Bristol-Myers Squibb Company (2020 sales of $42.52 billion of which 28% was Prioritized Brands-Revlimid), Baxter International Inc. ($11.67 billion of which 52% was Americas), and Novartis AG which is based in SWITZERLAND (46.58 billion Swiss Francs [US$50.41 billion] of which 78% was Innovative Medicines).

Sales Analysis. During the second quarter of 2021, sales at Johnson & Johnson totalled $23.31 billion. This is an increase of 27.1% from the $18.34 billion in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at Johnson & Johnson in the previous 35 quarters. During the first two quarters of 2021, sales totalled $45.63 billion, which is 16.9% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Johnson & Johnson were $82.58 billion. This is a very small increase of 0.6% versus 2019, when the company's sales were $82.06 billion. This was the fifth consecutive year of sales increases at Johnson & Johnson (and since 2015, sales have increased a total of 18%). Sales of Pharmaceutical saw an increase that was more than double the company's growth rate: sales were up 8.0% in 2020, from $42.20 billion to $45.57 billion. Johnson & Johnson also saw significant increases in sales in Consumer (up 1.1% to $14.05 billion) . Not all segments of Johnson & Johnson experienced an increase in sales in 2020: sales of Medical Devices fell 11.6% to $22.96 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Johnson & Johnson
  Stock Performance Chart for Johnson & Johnson
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 164.75
(Figures in U.S. Dollars)
1 Week -1.3%   13 Weeks -8.2%  
4 Weeks 1.7%   52 Weeks 10.4%  
Johnson & Johnson Key Data:
  Ticker: JNJ Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 82,584,000,000
(Year Ending Jan 2021).
Employees: 134,500
  Currency: U.S. Dollars Market Cap: 433,620,187,750
  Fiscal Yr Ends: December Shares Outstanding: 2,631,989,000
  Share Type: Common Closely Held Shares: 2,146,009
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.